ImmunAID seeks new biomarkers able to identify and classify more rapidly and more accurately autoinflammatory disorders
Identify a common signature to SAID enabling rapid differential diagnosis
Provide deep characterization of each specific pathogenic pathway and build dedicated analysis kits
Build a robust algorithm enabling reliable triage among the whole SAID spectrum
Grant agreement no: 779295
Funded under: H2020-EU.3.1.1.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779295